Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS

Clinical trial NCT00360438 · COMPLETED

Trial details

NCT number: NCT00360438
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia Lymphoma Tumor Lysis Syndrome

Start date: 2006-07-01
Primary completion: 2007-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.